Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
Jump to:
Preferred Name | ocriplasmin | |
Synonyms |
|
|
ID |
http://purl.obolibrary.org/obo/dinto_DB08888 |
|
AHFScode |
52:92
|
|
ATCCode |
S01AX22
|
|
binds |
http://purl.obolibrary.org/obo/dinto_3733 |
|
CASRN |
1048016-9-6
|
|
DBBrand |
jetrea
|
|
Definition |
Ocriplasmin is a recombinant truncated form of human plasmin with a molecular weight of 27.2 kDa produced by recombinant DNA technology in a Pichia pastoris expression system. Ocriplasmin is a protein made up of 249 amino acids and has two peptide chains. Agent for pharmacologic vitreolysis; thrombolytic agent. FDA approved in October 17, 2012.
|
|
has pharmacological target | ||
label |
ocriplasmin
|
|
prefixIRI |
obo2:dinto_DB08888
|
|
prefLabel |
ocriplasmin
|
|
related with |
http://purl.obolibrary.org/obo/dinto_3733 |
|
xref |
Wikipedia:http://en.wikipedia.org/wiki/Ocriplasmin RxList:http://www.rxlist.com/jetrea-drug.htm Drugs.com:http://www.drugs.com/jetrea.html National Drug Code Directory:24856-001-00
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping